NAMM vs IVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 22, 2026

NAMM

60.9
AI Score
VS
NAMM Wins

IVF

57.2
AI Score

Investment Advisor Scores

NAMM

61score
Recommendation
HOLD

IVF

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMM IVF Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 5.1% 16.7% IVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 60.9/100 57.2/100 NAMM
Profit Margin 122.5% -70.2% NAMM
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NAMM 1M: -21.0% · 3M: -34.9% IVF 1M: -10.9% · 3M: -61.4%

Current Technical Phase

NAMM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 36

RSI (14): 36.1 · Price: $1.15

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 44

RSI (14): 43.6 · Price: $0.94

Fundamentals Snapshot

Metric NAMM IVF
Market Cap — —
Forward P/E 0.6 -0.1
Trailing P/E 0.7 0.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.5% 0.4%
Operating Margin 0.3% -0.6%
EPS 1.72 338.48
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NAMM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.